Page last updated: 2024-12-05

quintozene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Quintozene, also known as PCNB (pentachloronitrobenzene), is a broad-spectrum fungicide that was widely used to control soilborne diseases in a variety of crops. It is synthesized by the nitration of pentachlorobenzene. Quintozene is highly effective against a range of fungal pathogens, including those that cause damping-off, root rot, and leaf spot diseases. However, its use has been restricted in many countries due to concerns about its potential toxicity to humans and the environment. Quintozene is a persistent organic pollutant (POP) that can accumulate in soil and water, posing risks to wildlife and human health. It has been linked to reproductive and developmental problems in animals and humans. Despite its limitations, quintozene continues to be studied for its potential applications in certain specialized settings. For example, research is ongoing to explore its potential use as a biocontrol agent against certain fungal pathogens that are resistant to other fungicides.'

quintozene: active ingredient of variety of fungicides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

pentachloronitrobenzene : A C-nitro compound that is nitrobenzene in which every hydrogen has been replaced by a chlorine. A fungicide used on a variety of crops, including cotton, rice and seed grains, it is no longer approved for use within the European Union. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6720
CHEMBL ID468759
CHEBI ID34908
SCHEMBL ID69247
MeSH IDM0047575

Synonyms (127)

Synonym
BIDD:ER0635
pentachloronitrobenzene (pcnb)
olpisan
1,2,3,4,5-pentachloro-6-nitro-benzene
benezene, pentachloronitro-
1,2,3,4,5-pentachloro-6-nitrobenzene
fomac 2
quintozen
pcnb
marisan forte
avicol
wln: wnr bg cg dg eg fg
phomasan
pentachoronitrobenzene
tritisan
kp 2
nsc58427
quintocene
avicol, pesticide
batrilex
benzene, pentachloronitro-
pentachloronitrobenzol
brassicol super
nci-c00419
tilcarex
chinozan
terraclor 30 g
pentachlornitrobenzol
botrilex
brassicol
terrafun
terrachlor
pentachloronitrobenzene
fartox
fungiclor
kobu
quintozene
quinosan
brassicol 75
gc 3944-3-4
terraclor
liro-pcnb
kobutol
pkhnb
pentagen
82-68-8
nsc-58427
nitropentachlorobenzene
tri-pcnb
NCGC00091305-01
ccris 495
einecs 201-435-0
avicol (pesticide)
avicol, pesticide (van)
hoe 026014
ai-23024
olin terraclor technical grade pcnb 99% soil fungicide
technical grade pcnb 95%
benzene, nitropentachloro-
quintozene [bsi:iso]
rcra waste number u185
caswell no. 640
quintozine
pentachlornitrobenzol [german]
ai3-23024
nsc 58427
rcra waste no. u185
pcnb technical material for manufacturing purposes only
olin terraclor 75% wettable powder
pcnb 100
brn 1914324
epa pesticide chemical code 056502
quintobenzene
terrazan
101 brand pcnb 75 wettable
saniclor 30
hsdb 1749
rtu 1010
pentachloronitrobenzene, plant cell culture tested, bioreagent, >=94% (gc), powder
pentachloronitrobenzene, >=94%
NCGC00091305-02
NCIOPEN2_002667
NCGC00091305-03
smr000778040
MLS002454434
CHEMBL468759
chebi:34908 ,
P0032
A840414
1,2,3,4,5-pentakis(chloranyl)-6-nitro-benzene
EN300-82484
NCGC00091305-04
NCGC00091305-05
cas-82-68-8
NCGC00254962-01
dtxsid2021105 ,
tox21_301060
dtxcid301105
NCGC00259496-01
tox21_201947
unii-q37g40s4s8
benzene, 1,2,3,4,5-pentachloro-6-nitro-
q37g40s4s8 ,
FT-0631375
2,3,4,5,6-pentachloronitrobenzene
pkhnc
AKOS015902907
quintozene [hsdb]
quintozene [iso]
quintozene [iarc]
quintozene [mi]
SCHEMBL69247
turfcide (salt/mix)
1,2,3,4,5-pentachloro-6-nitrobenzene #
tri-pcnb (salt/mix)
trim (salt/mix)
tubergran (salt/mix)
quintozene, pestanal(r), analytical standard
quintozene 100 microg/ml in cyclohexane
quintozene 10 microg/ml in cyclohexane
quintozene 100 microg/ml in acetonitrile
pentachloronitrobenzene 1000 microg/ml in acetone
Q418683
mfcd00007065
pentachloronitrobenzene powder quintozene powder
BS-25924
pcnb, quintozene

Research Excerpts

Overview

Quintozene is a fungicide containing the active ingredient, pentachloronitrobenzene (PCNB) It is used to control "snow mold" on golf courses in temperate regions of North America.

ExcerptReferenceRelevance
"Quintozene is a fungicide containing the active ingredient, pentachloronitrobenzene (PCNB) that is used to control "snow mold" on golf courses in temperate regions of North America. "( Effects of formulations of the fungicide, pentachloronitrobenzene on early life stage development of the Japanese medaka (Oryzias latipes).
Dillon, PJ; Metcalfe, CD; Metcalfe, TL, 2008
)
1.79

Toxicity

ExcerptReferenceRelevance
" However, toxic effect data of PCNB on terrestrial invertebrate are not available till now."( Bioaccumulation and toxicity of pentachloronitrobenzene to earthworm (Eisenia fetida).
Li, M; Wang, Y; Xu, G; Yu, R; Yu, Y, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
"Hexachlorobenzene (HCB), pentachloronitrobenzene (PCNB), and 4-chloroaniline (4-CA) were dosed into the water of small experimental ponds in Southern Germany."( Long-term fate of organochlorine xenobiotics in aquatic ecosystems. Distribution, residual behavior, and metabolism of hexachlorobenzene, pentachloronitrobenzene, and 4-chloroaniline in small experimental ponds.
Klein, W; Korte, F; Lay, JP; Schauerte, W, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
pentachlorobenzenesAny member of the class of chlorobenzenes in which a benzene ring is substituted by five chloro groups.
aromatic fungicideAn organic aromatic compound that has been used as a fungicide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (27)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency35.72890.002541.796015,848.9004AID1347395; AID1347398
SMAD family member 2Homo sapiens (human)Potency52.86880.173734.304761.8120AID1346859; AID1346924
SMAD family member 3Homo sapiens (human)Potency52.86880.173734.304761.8120AID1346859; AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency10.28080.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency30.58700.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743036; AID743042; AID743054
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency41.56360.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency15.35530.000417.946075.1148AID1346784
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency26.33580.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency13.61590.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency7.77770.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency53.98340.001530.607315,848.9004AID1224841; AID1224848; AID1224849
farnesoid X nuclear receptorHomo sapiens (human)Potency48.60610.375827.485161.6524AID588526; AID743217; AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency68.58960.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency40.34900.000229.305416,493.5996AID743075; AID743079; AID743080
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency58.29290.001024.504861.6448AID743212; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency39.09380.001019.414170.9645AID588536; AID588537; AID743094; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency51.95360.023723.228263.5986AID743222; AID743223
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency61.13060.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency57.41770.001628.015177.1139AID1259395
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency61.644819.739145.978464.9432AID1159509
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency3.16230.010039.53711,122.0200AID588547
potassium voltage-gated channel subfamily H member 2 isoform dHomo sapiens (human)Potency11.22020.01789.637444.6684AID588834
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency34.37620.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency12.29980.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency20.87620.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
lethal factor (plasmid)Bacillus anthracis str. A2012Potency19.95260.020010.786931.6228AID912
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID376577Antifungal activity against Colletotrichum fragariae assessed as zone of inhibition2000Journal of natural products, Aug, Volume: 63, Issue:8
A new 2D-TLC bioautography method for the discovery of novel antifungal agents To control plant pathogens.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (82)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (29.27)18.7374
1990's9 (10.98)18.2507
2000's19 (23.17)29.6817
2010's17 (20.73)24.3611
2020's13 (15.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.54 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index57.69 (26.88)
Search Engine Supply Index3.09 (0.95)

This Compound (30.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.12%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other88 (98.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]